Evidence map›Paper›PMID 39470242›Full record

ArticleMicrobiology resource announcements2024

Complete genome sequences of nine double recombinant vaccine-derived novel oral poliovirus type 2 genomes from Nigeria 2023-2024.

Christina J Castro, Bamidele Soji Oderinde, Katherine D Poston, Kabir Yusuf Mawashi, Kelley Bullard, Monilade Akinola, Caeden Meade, Hongmei Liu, Fang Hu, James E Bullows and 11 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology resource announcements, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Christina J CastroTanaq Management Services, LLC, contracting company for the Polio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0001-6452-1540
Bamidele Soji OderindeWorld Health Organization National Polio Laboratory, University of Maiduguri Teaching Hospital, Maiduguri, Borno State, Nigeria.
Katherine D PostonTanaq Management Services, LLC, contracting company for the Polio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Kabir Yusuf MawashiWorld Health Organization National Polio Laboratory, University of Maiduguri Teaching Hospital, Maiduguri, Borno State, Nigeria.
Kelley BullardPolio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Monilade AkinolaWorld Health Organization National Polio Laboratory, University of Maiduguri Teaching Hospital, Maiduguri, Borno State, Nigeria.
Caeden MeadeTanaq Management Services, LLC, contracting company for the Polio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Hongmei LiuPolio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Fang HuPolio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
James E BullowsTanaq Management Services, LLC, contracting company for the Polio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Zachary GonzalezTanaq Management Services, LLC, contracting company for the Polio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Hong PangPolio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Sarah SarrisTanaq Management Services, LLC, contracting company for the Polio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Chadi AghaTanaq Management Services, LLC, contracting company for the Polio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Naomi Dybdahl-SissokoPolio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Daniel B PerryTanaq Management Services, LLC, contracting company for the Polio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Larin McDuffiePolio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Elizabeth HendersonPolio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Cara C BurnsPolio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Jaume JorbaPolio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0001-6552-9878
Marycelin BabaWorld Health Organization National Polio Laboratory, University of Maiduguri Teaching Hospital, Maiduguri, Borno State, Nigeria.

Funding

World Health Organization 001
6 · The paper itself

Abstract

We report the complete genome sequences of nine double recombinant vaccine-derived novel oral poliovirus type 2 genomes from acute flaccid paralysis (AFP) cases (

Indexed as

next generation sequencingnOPV2poliovirus

Identifiers

PMID39470242
PMCPMC11636317

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.